On Friday, the Fifth Circuit United States Court of Appeals issued a ruling in the case of Louisiana v. FDA, which rendered a major blow to the abortion industry. The Fifth Circuit temporarily blocked the 2023 changes the Food and Drug Administration (FDA) made to its risk evaluation and mitigation strategy (REMS) rule, which allowed the abortion pill Mifepristone to be distributed over the counter and by mail, without medical safeguards or supervision.
LA’s Attorney General Liz Murrill shares the “victory for Life” on social media:
🚨BREAKING: Victory for Life! U.S. Fifth Circuit blocks Biden abortion regime that facilitated the death of thousands of Louisiana babies through mail-order abortion pills.
The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other… pic.twitter.com/1ROMOUMXrb
— Attorney General Liz…




